{"id":116319,"date":"2021-06-09T08:00:00","date_gmt":"2021-06-09T08:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2878972"},"modified":"2021-06-09T08:00:00","modified_gmt":"2021-06-09T08:00:00","slug":"hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/","title":{"rendered":"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities."},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Hemorrhoids%20Pipeline%20(2).png?1623216833631\" alt=\"Hemorrhoids Pipeline (2)\" width=\"646\" height=\"301\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">\\Involved pharmaceutical companies in the Hemorrhoids market are Nivagen Pharmaceuticals Inc.\u00a0<\/span><span style=\"font-weight: 400;\">Edesa Biotech, Citius Pharmaceuticals, and others.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight\u2019s <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline report<\/strong><\/a><span style=\"font-weight: 400;\"> highlights the details around Hemorrhoids, which are swollen and inflamed veins around the anus or in the lower rectum. The Hemorrhoids report provides a disease overview, pipeline scenario, and therapeutic assessment of the key pipeline therapies in this domain. The <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids report<\/strong><\/a><span style=\"font-weight: 400;\"> also highlights the unmet needs concerning the development of Hemorrhoids.<\/span><\/p>\n<p><strong>Some of the key highlights of <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>the Hemorrhoids Pipeline<\/strong><\/a><strong> report<\/strong><span style=\"font-weight: 400;\">&#8211;<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Nivagen Pharmaceuticals Inc. initiated a randomized, double-blind, placebo-controlled, multicenter, parallel-group study of the safety and efficacy of Hydrocortisone Acetate Suppositories, 25 mg compared to placebo suppositories in the treatment of symptomatic internal hemorrhoids.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Citius Pharmaceutical is developing its proprietary topical formulation of hydrocortisone (3%) and lidocaine (5%) to provide anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key companies involved in the <\/span><strong>Hemorrhoids Pipeline<\/strong><span style=\"font-weight: 400;\"> are Nivagen Pharmaceuticals Inc., Edesa Biotech, Citius Pharmaceuticals, and others.\u00a0<\/span><\/li>\n<\/ul>\n<p><strong>Request for Sample @<\/strong> <a href=\"https:\/\/www.delveinsight.com\/sample-request\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline Insights<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids<\/strong><\/a><span style=\"font-weight: 400;\">, also called piles, are swollen and inflamed veins around the anus or in the lower rectum. The two types of hemorrhoids are external hemorrhoids, which form under the skin around the anus, and internal hemorrhoids, which form in the lining of the anus and lower rectum.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline Emerging Therapies<\/strong><\/a><strong>: Drug Profile<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><strong>Hydrocortisone Acetate Suppository: Nivagen Pharmaceuticals Inc.<\/strong><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over-the-counter products across the globe.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><strong>lidocaine: Citius Pharmaceuticals<\/strong><\/li>\n<\/ul>\n<p><strong>Citius Pharmaceuticals <\/strong><span style=\"font-weight: 400;\">threw the light by stating that although there are numerous prescription and over-the-counter (OTC) products commonly used to treat hemorrhoids, none currently possess safety and efficacy data generated from rigorously conducted clinical trials. It is currently in the phase II stage of development.<\/span><\/p>\n<p><strong>Know More Information @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline Drugs<\/strong><\/a><\/p>\n<p><strong>Key Pipeline Therapies along with companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Hydrocortisone Acetate Suppository: Nivagen Pharmaceuticals Inc.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">EB02: Edesa Biotech<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">10.1.Halobetasol\/lidocaine: Citius Pharmaceuticals<\/span><\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Therapeutics Assessment<\/strong><\/a><\/p>\n<p><strong>By Product Type<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Mono<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Combination<\/span><\/li>\n<\/ul>\n<p><strong>By Stage<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Discovery\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Pre-clinical<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">IND<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Phase I<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Phase II<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Phase III<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Pre-registration<\/span><\/li>\n<\/ul>\n<p><strong>By Route of Administration<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Intravenous<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Inhalation<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Oral<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Subcutaneous\u00a0<\/span><\/li>\n<\/ul>\n<p><strong>By Molecule Type<\/strong><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Small Molecule\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Gene Therapy<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Stem Cell Therapy<\/span><\/li>\n<\/ul>\n<p><strong>By Mechanism of Action<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Protease Inhibitors<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Immunomodulatory<\/span><\/li>\n<\/ul>\n<p><strong>By Targets<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Protease\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Immune System<\/span><\/li>\n<\/ul>\n<p><strong>Contact Here for More Information @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline Assessment<\/strong><\/a><\/p>\n<p><strong>Scope of the Hemorrhoids Report<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Coverage- Global<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key Market Players- Nivagen Pharmaceuticals Inc. Edesa Biotech, Citius Pharmaceuticals, and others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key Hemorrhoids Pipeline Therapies:- Hydrocortisone Acetate Suppository, EB02, Lidocaine, and others<\/span><\/li>\n<\/ul>\n<p><strong>Table of Content<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">1<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Report Introduction<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">2<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">3<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Current Treatment Patterns<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">4<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids &#8211; DelveInsight&#8217;s Analytical Perspective<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">5<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Therapeutic Assessment<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">6<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Late Stage Products (Phase-III)<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">7<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Mid Stage Products (Phase-II)<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">8<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Early Stage Products (Phase-I)<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">9<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Pre-clinical Products and Discovery Stage Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">10<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Inactive Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">11<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Dormant Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">12<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Discontinued Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">13<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Product Profiles<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">14<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Key Companies<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">15<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Key Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">16<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Dormant and Discontinued Products<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">17<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Unmet Needs<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">18<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Future Perspectives<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">19<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Hemorrhoids Analyst Review\u00a0<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">20<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Appendix<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 6.45806%; height: 17px; text-align: center;\">21<\/td>\n<td style=\"width: 50.7178%; height: 17px;\"><span style=\"font-weight: 400;\">Report Methodology<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Know more of what&#8217;s covered in the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline Assessment<\/strong><\/a><strong> report<\/strong><\/p>\n<p><strong>Key Questions Answered in the Hemorrhoids report-<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the current options for <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids treatment<\/strong><\/a><span style=\"font-weight: 400;\">?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many companies are developing therapies for the treatment of Hemorrhoids?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the principal therapies developed by these companies in the industry?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many therapies are developed by each company for the treatment of Hemorrhoids?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many Hemorrhoids emerging therapies are in early-stage, mid-stage, and late stage of development for the treatment of Hemorrhoids?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Out of total pipeline products, how many therapies are given as a monotherapy and in combination with other therapies?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and major licensing activities that will impact Hemorrhoids market?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Which are the dormant and discontinued products and the reasons for the same?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What is the unmet need for current therapies for the treatment of Hemorrhoids?\u00a0\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the recent novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing Hemorrhoids therapies?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the clinical studies going on for Hemorrhoids and their status?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the results of the clinical studies and their safety and efficacy?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the key designations that have been granted for the emerging therapies for Hemorrhoids?\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many patents are granted and pending for the emerging therapies for the treatment of Hemorrhoids?\u00a0<\/span><\/li>\n<\/ul>\n<p><strong>Request for demo @ <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Pipeline<\/strong><\/a><strong> and get a walk-through of our report<\/strong><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-market?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217; s Hemorrhoids Market Insights, Epidemiology and Market Forecast 2030 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/hemorrhoids-epidemiology-forecast?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Hemorrhoids Epidemiology<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s Hemorrhoids &#8211; Epidemiology Forecast 2030 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/crohns-disease-cd-market?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Crohn&#8217;s Disease Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217; s Crohn&#8217;s Disease Market Insights, Epidemiology and Market Forecast &#8211; 2030 report<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/crohns-disease-cd-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Crohn&#8217;s Disease Pipeline<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Crohn&#8217;s Disease Pipeline Insights, 2021 report<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/ulcerative-colitis-uc-market?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Ulcerative Colitis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217; s <\/span><strong>Ulcerative Colitis <\/strong><span style=\"font-weight: 400;\">Market Insights, Epidemiology and Market Forecast 2030 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/ulcerative-colitis-uc-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Ulcerative Colitis Pipeline<\/strong><\/a><strong>\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Ulcerative Colitis Pipeline Insights, 2021 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/colorectal-cancer-crc-market?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Colorectal Cancer Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217; s <\/span><strong>Colorectal Cancer <\/strong><span style=\"font-weight: 400;\">Market Insights, Epidemiology and Market Forecast 2030 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/colorectal-cancer-crc-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Colorectal Cancer Pipeline<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Colorectal Cancer Pipeline Insights, 2021 report.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/anal-cancer-market?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Anal Cancer Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217; s Anal Cancer Market Insights, Epidemiology and Market Forecast &#8211; 2030<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/anal-cancer-pipeline-insight?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>Anal Cancer Pipeline<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Anal Cancer Pipeline Insights, 2021 report<\/span><\/p>\n<p><strong>Visit on our blog section-<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/digestive-disorders\/\">Companies In Digestive Disorders Market<\/a><\/strong><\/li>\n<li style=\"font-weight: 400;\"><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/pharma-happenings-for-roche-secura-verastem\/\">Roche&#8217;s Oral SMA Therapy; Roche&#8217;s Etrolizumab<\/a><\/strong><\/li>\n<li style=\"font-weight: 400;\"><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/colorectal-cancer-clinical-and-market-scenario\/\">Colorectal Cancer Market Analysis and Market Forecast<\/a><\/strong><\/li>\n<li style=\"font-weight: 400;\"><strong><a href=\"https:\/\/www.delveinsight.com\/blog\/most-common-cancers-2\/\">Top Five Prevalent Cancers in the World<\/a><\/strong><\/li>\n<\/ul>\n<p><strong>About DelveInsight<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>DelveInsight<\/strong><\/a><span style=\"font-weight: 400;\"> is a leading Business Consultant &amp; Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare &amp; pharma market research reports through our subscription-based platform <\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=icrowdnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\"><strong>PharmDelve<\/strong><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsmarketshare\/\" rel=\"tag\">hemorrhoidsmarketshare<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsmarketreport\/\" rel=\"tag\">hemorrhoidsmarketreport<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsmarket\/\" rel=\"tag\">hemorrhoidsmarket<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsepidemiologysegmentation\/\" rel=\"tag\">hemorrhoidsepidemiologysegmentation<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsepidemiology\/\" rel=\"tag\">hemorrhoidsepidemiology<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsemergingtherapies\/\" rel=\"tag\">hemorrhoidsemergingtherapies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsclinicaltrails\/\" rel=\"tag\">hemorrhoidsclinicaltrails<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsclinicalphases\/\" rel=\"tag\">hemorrhoidsclinicalphases<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidspipeline\/\" rel=\"tag\">hemorrhoidspipeline<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoids\/\" rel=\"tag\">Hemorrhoids<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/hemorrhoidsmarketinsights\/\" rel=\"tag\">hemorrhoidsmarketinsights<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Shruti Thakur <a href=\"mailto:info@delveinsight.com\">info@delveinsight.com<\/a> +1(919)321-6187<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Shruti Thakur<br \/> <a href=\"mailto:info@delveinsight.com\">info@delveinsight.com<\/a><br \/> +1(919)321-6187<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\">Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities.<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; \\Involved pharmaceutical companies in the Hemorrhoids market are Nivagen Pharmaceuticals Inc.&nbsp;Edesa Biotech, Citius Pharmaceuticals, and others. DelveInsight&rsquo;s Hemorrhoids Pipeline report highlights the details around Hemorrhoids, which are swollen and inflamed veins around the anus or in the lower rectum. The Hemorrhoids report provides a disease overview, pipeline scenario, and therapeutic assessment of the [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\">Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities.<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-116319","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business\" \/>\n<meta property=\"og:description\" content=\"&nbsp; &nbsp; Involved pharmaceutical companies in the Hemorrhoids market are Nivagen Pharmaceuticals Inc.&nbsp;Edesa Biotech, Citius Pharmaceuticals, and others. DelveInsight&rsquo;s Hemorrhoids Pipeline report highlights the details around Hemorrhoids, which are swollen and inflamed veins around the anus or in the lower rectum. The Hemorrhoids report provides a disease overview, pipeline scenario, and therapeutic assessment of the [&hellip;] The post Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-09T08:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\",\"name\":\"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png\",\"datePublished\":\"2021-06-09T08:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/","og_locale":"en_US","og_type":"article","og_title":"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business","og_description":"&nbsp; &nbsp; Involved pharmaceutical companies in the Hemorrhoids market are Nivagen Pharmaceuticals Inc.&nbsp;Edesa Biotech, Citius Pharmaceuticals, and others. DelveInsight&rsquo;s Hemorrhoids Pipeline report highlights the details around Hemorrhoids, which are swollen and inflamed veins around the anus or in the lower rectum. The Hemorrhoids report provides a disease overview, pipeline scenario, and therapeutic assessment of the [&hellip;] The post Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/","og_site_name":"Business","article_published_time":"2021-06-09T08:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/","url":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/","name":"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities. - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png","datePublished":"2021-06-09T08:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-Delveinsight20Logo-1.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/09\/hemorrhoids-pipeline-analysis-key-pharma-players-set-to-develop-innovative-therapies-and-explore-innumerable-opportunities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Hemorrhoids Pipeline Analysis: Key Pharma Players Set to Develop Innovative Therapies and Explore Innumerable Opportunities."}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/116319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=116319"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/116319\/revisions"}],"predecessor-version":[{"id":116320,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/116319\/revisions\/116320"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=116319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=116319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=116319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}